Sun Pharmaceutical Industries Ltd (SUN.NS)
7 Dec 2018
Dec 5 Indian shares hit a one-week closing low on Wednesday after the country's central bank left interest rates unchanged, while resurgent trade worries dented global sentiment.
Dec 3 Shares of India's Sun Pharmaceutical Industries sank more than 10 percent on Monday after a report of a regulatory probe against the country's biggest drug manufacturer by market value.
Nov 13 Sun Pharmaceutical Industries was sent to an unexpected second-quarter loss by a one-off charge for an antitrust litigation settlement.
Nov 13 Sun Pharmaceutical Industries Ltd , India's largest drugmaker by market capitalisation, posted a surprise quarterly loss on Tuesday, hurt by a one-time charge due to a legal settlement.
To access the newsletter, click on the link: http://share.thomsonreuters.com/assets/newsletters/Indiamorning/MNC_IN_08162018.pdf If you would like to receive this newsletter via email, please register at: https://forms.thomsonreuters.com/india-morning/ FACTORS TO WATCH 11:30 am: Banking Secretary Rajiv Kumar at launch of Canara Bank’s digital branch in New Delhi. LIVECHAT - BONDS UPDATE Reuters interest rate reporter Dhara Ranasinghe delves into gove
* Stock top gainer on NSE index (Adds details on U.S. and India sales, share movement)
Aug 14 India's largest drugmaker Sun Pharmaceutical Industries Ltd posted a first-quarter profit on Tuesday, beating street estimates.
MUMBAI, June 12 India's largest drugmaker Sun Pharmaceutical Industries Ltd said on Tuesday the U.S. Food and Drug Administration (FDA) cleared its Halol drug plant, which had been under supply restrictions due to quality control failures.